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Obesity is common in cats and, as in other species,is reported to be an unhealthy condition.
Compared with cats of normal body fat mass, obese
cats are at greater risk for developing nonallergic skin
conditions, hepatic lipidosis, and musculoskeletal dis-
orders.1 Obesity in cats also reduces tolerance of intra-
venously administered glucose loads and is suggested
to predispose cats to development of diabetes mellitus.2
Recently, researchers investigating the molecular basis
of obesity in a mouse model, C57BL/6J ob/ob, identified
and characterized a gene expressed in adipose tissue
that, when mutated, results in profound obesity and
type-II diabetes mellitus.3 The gene, called the ob gene
after the mouse model, was not unique to mice. Results
of cDNA hybridization analysis indicated that ob-like
genes are present in several vertebrate species, includ-
ing cats. Daily intraperitoneal injections of the ob pro-
tein induced a dose-dependent reduction of food
intake, body weight, and fat mass, and additionally in
ob/ob mice, return of glucose and insulin concentra-
tions to reference ranges.4-6 For its weight-reducing
effect, the ob product was named leptin, after the Greek
word for thin, leptós.4
Since the discovery of the ob gene, scientific inter-
est in the control of body energy balance and the
prospect of developing effective anti-obesity treatments
have driven an intensive research effort to determine
the function of leptin. Following the determination of
the ob nucleotide sequence, recombinant and chemi-
cally synthesized peptide sequences of leptin were pro-
duced and used to generate sensitive and specific
immunoassays for leptin.7-11 These assays have been
important tools for determining the function of leptin.
The purpose of the study reported here was to validate
a radioimmunoassay (RIA) based on antisera with
crossreactivity to leptins of several species for mea-
surement of serum leptin concentrations in domestic
cats, and evaluate the relationship between leptin con-
centrations and body fat mass as estimated by deuteri-
um oxide (D2O) dilution.
12
Materials and Methods
Cats—Nineteen adult male specific–pathogen-free cats
(mean ± SD; age, 3.0 ± 1.0 years; range, 1.1 to 3.5 years) that
weighed 4.9 ± 0.8 kg (range, 3.8 to 7.1 kg) were housed at
the Feline Nutrition and Pet Care Center, University of
California, Davis. Cats were kept in group cages in which
food was continuously available. Eleven cats received a com-
plete and balanced commercial extruded (dry-type) diet that
was labeled to contain 31% (wt/wt) crude protein, 10% crude
fat, 7% ash, 8% moisture, and 1.8% crude fiber. The remain-
ing 8 cats received a complete and balanced purified diet that
contained lactic caseina (200 g/kg), soybean protein isolateb
(200 g/kg), sucrosec (43 g/kg), animal tallowd (250 g/kg),
hydrogenated beef tallow flakese (100 g/kg), food-grade corn
starchf (142 g/kg), mineral mixture13 (50 g/kg), vitamin mix-
ture13 (10 g/kg), choline chlorideg (3 g/kg), taurineh
(1.5 g/kg), and dl-α-tocopherol acetatei (0.12 g/kg).
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Relationship between serum leptin 
immunoreactivity and body fat mass 
as estimated by use of a novel gas-phase
Fourier transform infrared spectroscopy 
deuterium dilution method in cats
Robert C. Backus, DVM, PhD; Peter J. Havel, DVM, PhD; Ronald L. Gingerich, PhD; Quinton R. Rogers, PhD 
Objective—To validate a recently developed com-
mercially available leptin radioimmunoassay (RIA) for
use with feline serum and evaluate the relationship
between serum leptin concentrations and body fat
mass in domestic cats.
Animals—19 sexually intact male specific–pathogen-
free domestic cats that weighed 3.8 to 7.1 kg and
were 1.1 to 3.5 years old.
Procedure—Specificity for feline leptin was evaluated
by use of gel filtration chromatography and reverse-
phase high-performance liquid chromatography frac-
tionation of serum. Body fat mass was determined by
use of the deuterium oxide (D2O) dilution method.
Serum water D2O enrichment was measured by use
of gas-phase Fourier transform infrared spectroscopy.
Results—Body fat mass and percentage body fat
ranged from 0.3 to 2.3 kg and 7.5 to 34.9%, respec-
tively. Serum leptin concentrations were lower in the
unfed versus the fed state and ranged between 1.6
and 4.9 ng/ml human equivalent (HE); mean ± SD
value was 2.9 ± 0.2 ng/ml HE. Leptin concentrations
increased with increasing body fat mass and percent-
age of body fat. 
Conclusions—Leptin is in the serum of domestic
cats in free (> 78%) and apparently bound forms. The
relationship between body fat and serum leptin con-
centration was similar to that observed in humans
and rodents and indicative of a lipostatic role for lep-
tin in cats. Cats that have an overabundance of body
fat appear to be less sensitive to the weight-normaliz-
ing action of leptin than cats of ideal body condition.
(Am J Vet Res 2000;61:796–801)
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Husbandry and experimental procedures were approved by
the university animal use and care committee and were in
compliance with the Guide for the Care and Use of Laboratory
Animals.14
Body fat determination—Body fat mass was estimated
by use of the isotopic dilution method of Lukaski et al.12 This
method was selected for practicality of use in a specific-
pathogen-free colony. A tracer dose (0.4 g/kg of body weight)
of D2O
j was administered IV after food and water were with-
held for 24 hours. Total body water mass was estimated by
detection of D2O in serum harvested from a blood sample
obtained from the jugular vein after a 2-hour equilibration
period. Size of the pool in which the tracer was diluted was
assumed to be the total body water mass. Overestimation of
total body water mass from deuterium exchange with labile
hydrogen was corrected by reducing the total body water
mass estimate by 2% of body weight.12 Body fat mass was
determined as the difference between body weight and lean
body mass, where lean body mass was estimated as total body
water mass divided by 0.744, a reported fractional moisture
content of lean body mass in cats.15
For D2O detection, water was extracted from 100 µl of
serum by a novel method. Serum was placed in a 2-ml screw-
cap tubek and held in a well that was formed on the inner sur-
face of the cap. A clean screw-cap tube base was inverted,
threaded on the cap, and carefully tightened so that the
serum in the cap would not contact the wall of the tube. The
inverted and capped tube was then placed, cap down, in glass
beads (approximately 2 mm in diameter) of a dry heated
bathl set at 45 C. The cap portion was buried so that the tube
stood vertically, exposed to air at 21 to 23 C. After 14 to 16
hours, approximately 40 µl of serum water typically would
condense on the walls of the tube. While still inverted, the
tube cap was replaced with a clean cap. The capped tube was
then centrifuged to collect the condensed water and stored at
–20 C until D2O detection.
Detection of D2O in the condensed water was accom-
plished by a modification of the gas-phase Fourier transform
infrared (FTIR) spectroscopy method described by Khaled et
al.16 In this method, 20 µl of condensed water was injected
into an evacuated (approx 20 mm Hg), heated (124 C) flash
injectorm fitted to a gas celln placed in the sample chamber of
a FTIR spectrometer.o An absorbance spectrum relative to
native water was obtained in 6 minutes by use of 200 scans
at a resolution of 4 wave numbers/cm (cm–1). Background
native water scans were of 800 iterations. Difference in
absorbance between native water and samples from cats
between 2,720 and 2,735 cm–1 indicated the presence of D2O.
This difference increased linearly (r ≥ 0.99) with enrich-
ments up to 0.067 atom percent excess (APE). Significant 
(P < 0.05) D2O depletion was not observed in the water
extraction procedure. Serum D2O enrichments were 
102 ± 4% (n = 6) and 102 ± 2% (10) of those determined by
mass spectroscopyp and single frequency infrared17 methods,
respectively (Fig 1). Intra- and interassay coefficients of vari-
ation were 1.0 and 1.7%, respectively.
Gel filtration fractionation of serum—The RIAq is
based on guinea pig antisera raised against recombinant
human leptin. To evaluate specificity of the antiserum for
feline leptin, leptin immunoreactivity was determined in 3
serum samples fractionated by use of gel filtration chro-
matography. Each serum sample was from a different cat.
One to 2 ml of serum were loaded on an allyl dextran-N,N'-
methylenebisacrylamider column equilibrated with 25-mM
phosphate-buffered saline solution, pH 7.4, at a flow rate of
35 ml/h. Before loading, the serum was centrifuged in an 
18 X 102-mm glass tubes at 8,000 X g for 30 minutes at 4 C
to remove particulate matter. Fractions were collected from
the column at 2-minute intervals in 12 X 75-mm borosilicate
glass tubes for 150 minutes. The fractionation procedure was
conducted at 4 C. Fractions were dried in the glass tubes by
centrifugal evaporationt at 21 to 23 C for 3 hours. The tube
contents were reconstituted by addition of 100 µl of human
blood bank plasma made leptin-free by use of charcoal
extraction. Leptin immunoreactivity in each tube was subse-
quently determined by use of the RIA kit; each fraction was
treated as a serum sample. Immediately before serum frac-
tionation, elution volumes of molecular weight markers,
albumin (67 kd), ovalbumin (43 kd), chymotrypsinogen A
(25 kd), and ribonuclease A (13.7 kd) were determined from
the ultraviolet absorbance at 280 nm of column eluent.
Leptin immunoreactivity was not found in eluent collected
during fractionation of the molecular markers.
Reverse-phase high-performance liquid chromatogra-
phy (HPLC) of serum—A modification of the HPLC method
of McGregor et al10 was used in fractionation of serum sam-
ples from 3 cats. Briefly, 0.5 ml of serum was loaded on a car-
tridgeu C18-conditioned sequentially with 5 ml of 86% ethanol
in 4% acetic acid followed by methanol, water, and 4% acetic
acid. The loaded cartridge was washed with 5 ml of water and
20% acetonitrile in 0.1% trifluroacetic acid (TFA). Adsorbed
leptin was eluted into 8 ml of 0.1% TFA with 3 ml of 80%
acetonitrile in 0.1% TFA. The diluted eluent (10 ml) was
injected onto a 3.9 X 300-mm C18-columnv equilibrated with
20% acetonitrile in 0.1% TFA with flow rate of 1.0 ml/min.
Acetonitrile in the mobile phase was linearly increased to
70% during a 65-minute period, beginning 15 minutes after
extract injection. Column eluent was collected at 1-minute
intervals in 12 X 75-mm glass tubes and dried by use of cen-
trifugal evaporation. Leptin immunoreactivity in the frac-
tions was determined by use of the procedure described in
gel filtration methods.
Leptin radioimmunoassay—Measurement of serum
leptin concentration was conducted as directed in the RIA kit
instructions.q Briefly, this involved incubation of 100 µl of
serum with 100 µl of an assay buffer and 100 µl antiserum in
12 X 75-mm glass tubes for 24 hours at 4 C. After incubation,
100 µl of solution that contained approximately 10,000 dis-
integrations/min of human recombinant leptin labeled with
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Figure 1—Correlation between serum deuterium oxide enrich-
ment (atom percentage excess [APE]) determined by use of
gas-phase Fourier transform infrared spectrometry (y-axis) with
that determined by use of mass spectrometry () and infrared
absorbance at a single frequency () (x-axis). The plotted line
represents the linear function y = 1.01x + < 0.01, derived from
least-squares analysis of the plotted points (r = 0.999).
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radioactive iodide (125I) was added and incubated for 24
hours at 4 C. The label bound to the RIA antiserum was pre-
cipitated by adding 1 ml of diluted rabbit anti-guinea pig
antisera solution to each tube and incubating for 20 minutes
at 4 C. The mixture was centrifuged at 2,000 X g for 20 min-
utes at 4 C. The precipitant was counted for 1 minute after
separation from the supernatant by pouring. Serum leptin
concentration was determined from the percentage of total
counts that were bound in the precipitant. 
Because the serum used in this determination was
obtained from blood collected from food-deprived cats, the
effectof food deprivation was investigated by determination
of leptin immunoreactivity in 11 cats before and after with-
holding of food for 24 hours.
Statistical analyses—Linear regression and correla-
tion analyses involving serum leptin immunoreactivity,
body fat mass, percentage body fat mass, and age were con-
ducted with a computer software program.w The effects of
diet and withholding food on serum leptin immunoreac-
tivity and body fat mass were evaluated by use of Mann-
Whitney tests. Differences were considered significant at 
P ≤ 0.05.
Results
Fractionation of serum by use of gel filtration
chromatography revealed that most of the leptin
immunoreactivity was concentrated in 2 peaks (Fig 2).
As indicated by molecular weight markers, the highest
peak eluted in fractions expected to contain proteins
that weighed between 15.7 and 20.7 kd. Linear inter-
polation indicated that the most immunoreactive frac-
tion could be expected to contain a 16-kd protein.
Leptin immunoreactivity in the smaller of the 2 peaks
was consistent with the presence of a protein in a mol-
ecular weight range greater than that of bovine serum
albumin. Total immunoreactivity (n = 3) was equiva-
lent to 6 to 26 ng of recombinant human leptin, and
the 2 immunoreactive peaks contained 75 ± 19% and
17 ± 6% of this total, respectively.
Reverse-phase HPLC fractionation of serum
revealed that virtually all leptin immunoreactivity was
within a single peak (Fig 3). Retention time of the peak
occurred slightly before the retention time of the 125I-
labeled human recombinant leptin used in the RIA.
Mean (± SEM) recovery of immunoreactivity in the
peak was 16.8 ± 5.6% (n = 3). In some specimens, a
portion of the pelleted bound leptin was noticed to be
lost during the separation of bound leptin from free
leptin, which resulted in a few small peaks in the HPLC
Figure 2—Leptin immunoreactivity (pg of human equivalents [HE]) of 2 ml of feline serum
fractionated by use of gel filtration chromatography. Open circles from left to right are
plots of the elution volumes of the molecular weight markers, bovine serum albumin
(64.5 kd), ovalbumin (46.3 kd), chymotrypsin A (20.7 kd), and ribonuclease A (15.7 kd),
respectively. The dashed line is a plot of the linear function estimated from least-squares
analysis of volume of elution as a function of relative molecular weight (y = –0.493x +
76.6; r = 0.947).  V = Void volume. 16 kd = Volume expected to contain leptin.
Figure 3—Leptin immunoreactivity (ng of human equivalents
[HE]) of 0.5 ml of solid phase-extracted feline serum fractionat-
ed by use of reverse-phase high-performance liquid chromatog-
raphy. Arrow indicates elution time for iodine 125-labeled recom-
binant human leptin. Dotted line indicates percentage of ace-
tonitrile in the mobile phase.
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profile. A peak at the 41-minute elution time was
believed to be such an artifact, because it was not con-
sistently observed.
Body fat mass and percentage body fat among cats
ranged from 0.3 to 2.3 kg and 7.5 to 34.9%, respec-
tively. Serum leptin immunoreactivity among cats
ranged between 1.7 and 5.0 ng/ml human equivalent
(HE) and was positively correlated with body fat mass
and percentage body fat. Leptin immunoreactivity
increased linearly  with increasing body fat mass (Fig
4). A similar relationship was observed between leptin
immunoreactivity and percentage of body fat. Serum
leptin immunoreactivity was not significantly (P =
0.19) correlated with lean body mass (r = 0.31).
Leptin immunoreactivity was repeatedly measured
in serum samples obtained from blood collected from
2 cats to assess intra- and interassay variance. Mean 
(± [SD/mean] X 100) leptin immunoreactivity of 8
replicates from 1 cat was 2.3 ng/ml ± 12.3% and from
the other cat was 11.4 ng/ml ± 3.9%. Mean leptin
immunoreactivities determined in assays conducted on
3 different days for these 2 cats were 2.6 ng/ml ± 11.3%
and 11.3 ng/ml ± 6.3%, respectively.
The 24-hour withholding of food may have affect-
ed serum leptin immunoreactivity. Mean (± SEM) lep-
tin immunoreactivity before food deprivation 
(2.0 ± 0.2 ng/ml HE) was greater than mean
immunoreactivity after food deprivation (1.7 ± 0.2
ng/ml HE), but not significantly (P = 0.051).
Cats given the commercial diet had greater 
(P = 0.02) leptin immunoreactivity (3.4 ± 0.3 ng/ml
HE) than cats given the purified diet (2.4 ± 0.1 ng/ml
HE), but an effect of diet could not be clearly dis-
cerned from that of body fat mass. The mean body fat
mass of cats given the commercial diet was nearly sig-
nificantly greater (P = 0.055) than that of cats given
the commercial purified diet. Percentage body fat of
cats given the commercial diet was not significantly
different from that of cats given the purified diet.
Serum leptin immunoreactivity was positively cor-
related (r = 0.66; P = 0.01) with age. Because body fat
mass and percentage body fat mass were also positive-
ly correlated with age (r = 0.80; P < 0.001 and r = 0.76;
P < 0.001, respectively), an age effect could not be dis-
tinguished.
Discussion
The finding of a weak hybridization signal in
murine ob cDNA probing of feline genomic DNA was
an initial indication that a leptin homolog occurs in
cats.3 We presumed that this leptin was bloodborne in
cats and attempted to measure it in the serum of lean
and overweight cats with a RIA based on antisera
raised against mouse, human, primate, and rat leptins.
Unfortunately, in initial trials, substantial immunoreac-
tivity was not observed. The cause for the negative
result was suspected to be a structural uniqueness of
feline leptin, which precluded binding to the tested
antisera. Evaluation of reported nucleotide sequences
of the ob genes of mice, humans, rats, chickens,18 and
pigs19 indicates that there are species differences in lep-
tin structure. Apparently, the antisera used in the study
reported here has affinity for a structural domain con-
served among many species, including cats. 
Gel filtration fractionation of serum was used in
our study to validate that leptin is a circulating factor
in cats. Indeed, substantial leptin immunoreactivity
was found in serum (Fig 2). Most of the immunore-
activity was in fractions that were expected to con-
tain protein of the molecular weight of leptin (16
kd). Similar results have been observed in gel filtra-
tion fractionation of human serum.9,10,20 Some of the
leptin immunoreactivity was observed in fractions
expected to contain proteins of much greater molec-
ular weight than leptin. Nonspecific immunoreactiv-
ity of the RIA antiserum with serum proteins could
explain this result. However, another possibility is
that certain serum proteins specifically bound the
125I-leptin label of the RIA. Human serum proteins
that weigh 66 to 280 kd bind leptin, and some of the
binding is quite specific for leptin.20 Circulating lep-
tin has been suggested to be the ligand for a splice
variant of the leptin receptor that has no apparent
transmembrane domain.21 This soluble receptor,
which has a predicted molecular weight of 92 kd,
may form circulating complexes with leptin.22 Such a
protein could account for the high molecular weight
leptin immunoreactivity detected in our study.
Presently, the function of a circulating leptin receptor
is speculative. Tartaglia21 has suggested that such a
receptor may mediate transport, modulate potency,
or facilitate clearance of leptin. The fraction of leptin
bound to the serum proteins of humans is reportedly
high in lean individuals and low in obese subjects.20
This may also be true in cats.
Results of HPLC fractionation of plasma further
indicated that the RIA antiserum was specific for feline
leptin. One immunoreactive peak, rather than 2, was
observed in this procedure (Fig 3). Similar results with
reverse-phase HPLC and gel chromatography have
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Figure 4—Relationship among serum leptin concentration, body
fat mass (), and percentage body fat () of adult male cats.
Linear regression functions of leptin concentration on body fat
mass (y = 1.20x – 1.67; r = 0.88; P < 0.001) and percentage body
fat (y = 0.08x + 1.40; r = 0.81; P < 0.001) are plotted as solid and
dashed lines, respectively.
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been reported for human serum.10 The peak eluted at
approximately the same time as the recombinant
human leptin standard, indicating that the serum con-
tained a leptin chemically similar to the standard. The
slight difference observed in retention time between
the feline samples and the human standard may indi-
cate a structural difference that affects hydrophobicity.
The low recovery of leptin immunoreactivity was sus-
pected to have resulted from loss in the C18-cartridge
extraction. To investigate this possibility, serum was
extracted after being spiked with the 125I-leptin label
used in the assay. The amount of label recovered (22%)
was similar to that recovered after HPLC fractionation
(20.8%). Some radiolabel (17.5%) passed though the
C18-cartridge during loading and washing. Most of the
label appeared to be retained on the C18-cartridge, with
a substantial amount adsorbed to the frits that retain
the silica gel packing. The extraction method used in
our study was developed for use on human plasma, but
recovery results were not reported.10
Serum leptin immunoreactivity among cats
increased with increasing percentage of body fat 
(Fig 4). Percentage of body fat ranged from a high
value of 35% to a low value of 7.5%. Results of previ-
ous research on subjective assessment of body fat has
indicated that approximately 22% body fat is ideal in
cats,23 and that body conditions among cats of our
study would be classified as thin to “heavy.” For those
cats with percentage of body fat near ideal in our
study, serum leptin immunoreactivity was approxi-
mately 3 ng/ml HE. This concentration is considerably
less than leptin concentrations found in serum of nor-
mal-weight human subjects.24-26 The low values proba-
bly resulted from lower affinity of the RIA antiserum
for feline leptin than its immunogen, recombinant
human leptin.
If leptin functions in cats as suggested in other
species, the high leptin concentrations detected in our
study would indicate an overabundance of body fat,
and appropriate changes in food intake, energy expen-
diture, and metabolism would be orchestrated by
hypothalamic nuclei to regulate body fat mass. If this
feedback mechanism completely corrected deviations
in fat mass, only transient changes in serum leptin con-
centration would be expected. In the study reported
here, cats that had an undesirably large amount of
body fat also had high serum leptin immunoreactivity.
Similar findings in humans and rodents have led to
postulation that most obese humans are resistant to
leptin.7,27 Many causes for this resistance have been
suggested, including intravascular defects that limit
free leptin from reaching the brain, impaired transport
of leptin across the blood-brain barrier, and faulty cel-
lular signal transduction at target tissues.28-30 Although
none of the cats in our study would be considered
obese,23 it would appear that resistance to the weight-
regulating effects of leptin may occur in obese cats.
Among cats of our study, a small (20%) but
notable decrease was observed in serum leptin
immunoreactivity with food deprivation, probably as a
manifestation of short-term changes in leptin secretion
by adipose tissue. In humans and rodents, circulating
concentrations of leptin decrease with brief periods of
fasting or energy restriction, and refeeding restores the
decrements in leptin concentration.28-30 Because insulin
and glucose appear to be secretogogues of leptin, such
short-term changes in energy balance may result from
changes in insulin and glucose concentrations.31 In the
fasted state, insulin and glucose concentrations are low
and, therefore, leptin secretion should be low. The
magnitude of reduction in circulating leptin
immunoreactivity observed among the cats of our
study was less substantial than that reported in rats and
humans.24,26 Because blood glucose concentration of
cats is not profoundly reduced by withholding of
food,32 the small change in serum leptin immunoreac-
tivity observed in cats of our study may reflect a small
change in glucose availability. Also, adipose glucose
use in cats appears to differ from that in humans and
rats. Acetate is preferred to glucose in lipogenesis in
cats, whereas glucose is the preferred substrate in
humans and rats.33
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rSephacryl S-100 Hiprep 16/60, Pharmacia Biotech, Alameda, Calif.
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tSS3 SpeedVac Concentrator System, Savant Instruments,
Farmingdale, NY.
uSep-Pak Classic, Waters Corp, Milford, Mass.
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